Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)

China flag China · Delayed Price · Currency is CNY
4.230
-0.040 (-0.94%)
Jun 12, 2025, 2:45 PM CST
14.32%
Market Cap 5.83B
Revenue (ttm) 3.25B
Net Income (ttm) 6.10M
Shares Out 1.37B
EPS (ttm) 0.00
PE Ratio 956.05
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,583,600
Average Volume 22,444,157
Open 4.120
Previous Close 4.270
Day's Range 4.120 - 4.300
52-Week Range 2.980 - 4.690
Beta 0.51
RSI 66.87
Earnings Date Aug 21, 2025

About SHE:002424

Guizhou Bailing Group Pharmaceutical Co., Ltd. research, develops, produces, and sells medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, powders, pills, tinctures, sprays, lotions, and cream for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases. Guizhou Bailing Group Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Anshun, China. [Read more]

Sector Healthcare
Founded 1999
Employees 6,582
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002424
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.